Appalachian State University
Boone, North Carolina, 28608, United States
NCT Number: NCT06804291
The goal of this clinical trial was to determine if and how the biomarkers neurofilament light (NfL), brain lipid binding protein (BLBP), and amyloid precursor protein (APP) accumulated over 72 hours in venous blood following running, cycling, or playing rugby as compared to a non-exercising control group. Participants in this study were recreationally active and healthy males and females 18 - 49 years of age. The main questions it aimed to answer was:
Do NfL, BLBP, and APP increase following exercise? Researchers compared the accumulation of NfL, BLBP, and NfL among runners, cyclists, rugby players, controls, and between sexes in each category.
Participants were asked to either run, bike, play a rugby match, or abstain from exercise. In the exercising group, blood was drawn from a vein prior to the activity, immediately after the activity, 30 minutes after the activity, 1 hour after the activity, 24 hours after the activity, 48 hours after the activity, and 72 hours after the activity. In the non-exercising group blood was drawn from a vein one time.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Boone, North Carolina, 28608, United States
Participants were recruited for this study from fall 2021 - spring 2022. Participants recruited to play in a rugby match were current members of the university men's and women's club rugby team. Running participants consisted of members of the university's men's and women's running teams as well as recreational runners. Cycling participants consisted of members of the university's cycling club as well as recreational cyclists. Male rugby athletes played two 40-minute halves while female rugby athletes played two 20-minute halves. These are typical match times for men's and women's rugby. Runners were asked to run 6.44 kilometers at their own pace, and cyclists were asked to cycle 39 kilometers at their own pace. A control group comprised of both sedentary and recreationally active individuals was also recruited and asked to refrain from exercise for 24 hours.
Blood was drawn from an antecubital vein in the exercising groups before and after exercise as well as 30 minutes, 1-, 24-, 48-, and 72-hours after exercise. Only one blood draw was taken in the control group.
The blood biomarkers neurofilament light (NfL), brain lipid binding protein (BLBP), and amyloid precursor protein were then measured in the venous blood and compared within groups, among groups, and between sexes.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants were expected to run 6.44 kilometers.
Other names: Jogging
Participants were expected to cycle 39 kilometers
Other names: Biking
Participants were expected to play in one rugby match.
Participants were asked to refrain from exercise for 24 hours.
Other names: Control
Time frame: Baseline, 0, 0.5, 1, 24, 48, 72 hours post-intervention.
Neurofilament light (NfL) was measured in venous blood samples collected from participants. NfL was measured using enzyme-linked immunosorbent assays (ELISAs) in pg·mL-1.
Time frame: Baseline, 0, 0.5, 1, 24, 48, 72 hours post-intervention.
Brain lipid binding protein (BLBP) was measured in venous blood samples collected from participants. BLBP was measured using enzyme-linked immunosorbent assays (ELISAs) in ng·mL-1.
Time frame: Baseline, 0, 0.5, 1, 24, 48, 72 hours post-intervention.
Amyloid precursor protein (APP) was measured in venous blood samples collected from participants. APP was measured using enzyme-linked immunosorbent assays (ELISAs) in ng·mL-1.
Appalachian State University
Other
The Effect of Different Exercise Modes on Serum Concentrations of NfL, APP, and BLBP: a Nonrandomized Control Trial Exploratory Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06818032
Healthy, Healthy Adult
Burlington, Vermont, United States
View Trial DetailsNCT06853249
Healthy Male and Female Subjects, Nutrition
Kiel, Germany
View Trial DetailsNCT06732804
Healthy Male and Female Subjects
Bayswater, Australia
View Trial DetailsNCT07140536
Healthy Male and Female Subjects
Aachen, Germany
View Trial Details